Oncology Meeting Resources

In this section, you can find all available abstracts, presentations and webcasts on OncologyPRO.

Here below, you can search across all meeting resources by session title, presentation title, presenter or keyword. Results can then be refined by topic, event and publication date.

The use of these presentations is for personal educational purposes only.
ESMO thanks the authors for their generosity.




Format available

https://oncologypro.esmo.org/Meeting-Resour...lorectal-cancer-Prospective-randomized-study

Background

Pathological examination is essential to determine the cancer stage in colorectal cancer (CRC) patients, and histological examination of lymph nodes plays a pivotal role ... The clinical usefulness of a new fat-dissociation method to detect lymph nodes from surgically resected specimen in colorectal cancer: Prospective randomized study

Date: 23 Nov 2019
Presenter: Shiki Fujino
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...mour-location-and-colorectal-cancer-survival

Background

Recent studies revealed contrasting prognostic roles of body-mass index (BMI) and tumor location in colorectal cancer (CRC). Given that right-sided and left-sided CRC may ... Body mass index, tumour location, and colorectal cancer survival

Date: 23 Nov 2019
Presenter: Dake Chu
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...ng-to-increased-number-of-CD4-CD45RB-T-cells

>Methods

Using 16S rRNA fluorescence in situ hybridization (FISH), we examined the abundance of H.bilis in 58 colorectal cancers (CRCs), 20 IBDs, 40 normal colorectal mucosae (NCs) and 20 adenomas

Date: 23 Nov 2019
Presenter: Xiangsheng Fu
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...-liver-metastases-development-and-validation

§1§General Surgery, Zhongshan Hospital, Fudan University, 200032 - Shanghai/CN, §2§Colorectal Cancer Center; Department Of General Surgery, Zhongshan Hospital, Fudan University, 200032 - Shanghai ...

Background

To modify the tumor burden score (TBS) and to develop a comprehensive and practical prognostic scoring system among Chinese patients with colorectal liver metastases (CRLM ... Comprehensive evaluation of relapse risk (CERR) score for colorectal liver metastases development and validation

Date: 23 Nov 2019
Presenter: Jianmin Xu
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...ucosal-invasive-cancer-after-local-resection

§Department Of Colorectal Surgery, National Cancer Center Hospital East, Chiba/JP, §12§Department Of Gastroenterology And Endoscopy, National Cancer Center Hospital East, Chiba/JP ... to stoma placement and impaired anal function. Thus, alternative treatments to prevent local metastasis are anticipated. This study assessed the safety of adjuvant chemoradiotherapy with capecitabine

Date: 23 Nov 2019
Presenter: Masaaki Noguchi
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...fers-prognostic-benefit-in-colorectal-cancer

haven’t clearly figured out the prognostic value of MICB in colorectal cancer (CRC). Here, we figured out the relationship between MICB and prognosis in a CRC cohort of Zhongshan Hospital. The prognostic ... High MICB expression confers prognostic benefit in colorectal cancer

Date: 23 Nov 2019
Presenter: Shanchao Yu
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...hed-nationwide-population-based-cohort-study

§1§Department Of Colorectal Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Taipei Medical University - Municipal Wan Fang Hospital, 116 - Taipei/TW, §2§Director & Attending ... Department Of Colorectal Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Taipei Medical University - Municipal Wan Fang Hospital, 116 - Taipei/TW

Date: 23 Nov 2019
Presenter: Chien-Hsin Chen
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...lonal-antibodies-A-machine-learning-analysis

§1§Colorectal Cancer Center; Department Of General Surgery, Zhongshan Hospital, Fudan University, 200032 - Shanghai/CN, §2§Colorectal Cancer Center; Department Of General Surgery, Zhongshan Hospital ...

Background

New predictive biomarkers for cetuximab-resistance for patients with RAS wild-type colorectal liver metastases (CRLM).

Methods

216 patients with initially ... Colorectal Cancer Center; Department Of General Surgery, Zhongshan Hospital, Fudan University, 200032 - Shanghai/CN ... Biomarker selection of liver metastatic colorectal patients for anti-EGFR monoclonal antibodies: A machine learning analysis

Date: 23 Nov 2019
Presenter: Yijiao Chen
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...RAS-BRAF-mutated-colorectal-liver-metastases

§1§Colorectal Cancer Center; Department Of General Surgery, Zhongshan Hospital, Fudan University, 200010 - shanghai/CN, §2§Colorectal Cancer Center; Department Of General Surgery, Zhongshan Hospital ...

Background

The type of liver resection (anatomical resection, AR or nonanatomical resection, NAR) for colorectal liver metastases (CRLM) is subject to debate. The debate may persist ... Colorectal Cancer Center; Department Of General Surgery, Zhongshan Hospital, Fudan University, 200010 - shanghai/CN ... Anatomical resections improve relapse-free survival in patients with KRAS/NRAS/BRAF- mutated colorectal liver metastases

Date: 23 Nov 2019
Presenter: Ye Wei
Resources: Abstract
Topic: Colon and Rectal Cancer

https://oncologypro.esmo.org/Meeting-Resour...sis-in-colorectal-cancer-with-CNS-metastases

Background

Brain metastases (BM) due to colorectal cancer (CRC) are an infrequent event. Previous research suggests that patients with pulmonary metastases, rectal primaries and KRAS ... Incidence, characteristics and prognosis in colorectal cancer with CNS metastases

Date: 23 Nov 2019
Presenter: Nicola Taylor
Resources: Abstract
Topic: Colon and Rectal Cancer